10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

GILEAD SCIENCES, INC.

Ticker: GILD   Fiscal Year: 2014

Consolidated Balance Sheets

Period Ending Dec 31, 2014 10-K (Filed: Feb 25, 2015)

(In Millions, except shares in actual)
 As ofAs of
 Dec 31, 2014Dec 31, 2013
Assets [Abstract]
Assets, Current [Abstract]
Cash and cash equivalents
$
10,027
2,113
Short-term marketable securities10119
Accounts receivable, net of allowances of $356 at December 31, 2014 and $252 at December 31, 20134,6352,182
Inventories1,3861,697
Deferred tax assets508331
Prepaid taxes391398
Prepaid expenses194166
Other current assets47291
Total current assets17,7146,997
 
Assets, Noncurrent [Abstract]
Property, plant and equipment, net1,6741,166
Long-term portion of prepaid royalties466199
Long-term deferred tax assets236190
Long-term marketable securities1,598439
Intangible assets, net11,07311,900
Goodwill1,1721,169
Other long-term assets731519
Total assets34,66422,579
 
Liabilities and Stockholders' Equity [Abstract]
Current liabilities [Abstract]
Accounts payable9551,256
Accrued government and other rebates2,3161,018
Accrued compensation and employee benefits316243
Income taxes payable10511
Other accrued liabilities1,4521,071
Deferred revenues134111
Current portion of long-term debt and other obligations, net4832,697
Total current liabilities5,7616,407
 
Liabilities, Noncurrent [Abstract]
Long-term Debt, net11,9213,939
Long-term income taxes payable562162
Long-term deferred tax liabilities5183
Other long-term obligations535179
Commitments and contingencies (Note 11)  
Temporary Equity [Abstract]
Equity component of currently redeemable convertible notes (Note 10)1564
Stockholders' Equity [Abstract]
Preferred stock, par value $0.001 per share; 5 shares authorized; none outstanding00
Common stock, par value $0.001 per share; shares authorized of 5,600 at December 31, 2014 and December 31, 2013; shares issued and outstanding of 1,499 at December 31, 2014 and 1,534 at December 31, 201322
Additional paid-in capital2,3915,386
Accumulated other comprehensive income (loss)301(124)
Retained earnings12,7326,106
Total Gilead stockholders equity15,42611,370
 
Noncontrolling interest393375
Total stockholders equity15,81911,745
 
Total liabilities and stockholders equity34,66422,579
 
External Links 
GILEAD SCIENCES, INC. (GILD) Fiscal Year 2014
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip